Biotech Zooms Into Breakout Zone On Hard-Fought Approval – Investor’s Business Daily

Speculation mounted into the weekend that Japanese authorities could be preparing to enter currency markets in a bid to halt…

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis…